Literature DB >> 28828984

The Efficacy and Potential Mechanisms of Chinese Herbal Medicine on Irritable Bowel Syndrome.

Zijuan Bi1, Yu Zheng1, Jianye Yuan1, Zhaoxiang Bian2.   

Abstract

Irritable bowel syndrome (IBS) is one of the most common functional bowel disorders (FBD), which is characterized by recurrent abdominal pain, abdominal bloating/distention associated with defecation or changed bowel habits. Currently, there is no evidence of obvious anatomic or physiologic abnormalities on the routine diagnostic examinations. There are multiple pathological factors involved in IBS responsible for its heterogeneous nature, although the exact etiology and pathology of IBS are not well known and it is disappointed to develop biomarkers for this disorder. These factors including low-grade inflammation, activation of immune system, changed intestinal microorganism, small intestinal bacterial overgrowth (SIBO), malabsorption of bile acid (BA), increased number of mast cells (MCs). Current pharmacologic treatment for IBS focuses on alleviation of its symptoms, but not on the elimination of its cause. Although there are a lot of conventional chemical medicines for IBS available, due to the limited clinical benefits, high medical expenses and severe side effects, many IBS patients have turned to alternative medicine, particularly Chinese herbal medicine (CHM). Chinese herbal therapies have been used for thousand years in eastern Asia and have been provided that they are effective in relieving symptoms among IBS patients. Generally, traditional Chinese herbal formulae (CHF) consisting of CHM can be easily adjusted in accordance with concrete conditions, which means the treatment is based on syndrome differentiation and varied from individual to individual. Meanwhile, CHF/CHM containing many different ingredients may act on multiple sites/pathways with potential synergistic effects and chemical reactions. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Chinese herbal medicine; Irritable bowel syndrome; efficacy; mast cells; mechanism; small intestinal bacterial overgrowth

Mesh:

Substances:

Year:  2017        PMID: 28828984     DOI: 10.2174/1381612823666170822101606

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  7 in total

1.  ICD-11: Impact on Traditional Chinese Medicine and World Healthcare Systems.

Authors:  Wai Ching Lam; Aiping Lyu; Zhaoxiang Bian
Journal:  Pharmaceut Med       Date:  2019-10

2.  An Overview of Systematic Reviews of Herbal Medicine for Irritable Bowel Syndrome.

Authors:  Hyejin Jun; Seok-Jae Ko; Keumji Kim; Jinsung Kim; Jae-Woo Park
Journal:  Front Pharmacol       Date:  2022-05-18       Impact factor: 5.988

3.  Metabolomics analysis of herb-partitioned moxibustion treatment on rats with diarrhea-predominant irritable bowel syndrome.

Authors:  Xianwei Lin; Xia Liu; Jingjing Xu; Kian-Kai Cheng; Jianan Cao; Tao Liu; Qiong Liu; Huan Zhong; Guiping Shen; Jiyang Dong; Xiaorong Chang
Journal:  Chin Med       Date:  2019-05-08       Impact factor: 5.455

4.  Efficacy of Compound Herbal Medicine Tong-Xie-Yao-Fang for Acute Radiation Enteritis and Its Potential Mechanisms: Evidence from Transcriptome Analysis.

Authors:  Cheng Yang; Jiayue Yang; Min Xia; Jianhong Wei; Yang Jiao; Qiang Zhan
Journal:  Biomed Res Int       Date:  2020-12-01       Impact factor: 3.411

5.  Factors affecting the use of herbal products in patients with Irritable Bowel Syndrome and their results: case-control study.

Authors:  Emin Gemcioglu; Nuray Yılmaz Cakmak; Salih Baser; Servet Kocaoz; Osman Ersoy
Journal:  BMC Gastroenterol       Date:  2022-02-04       Impact factor: 3.067

6.  Effect of Modified Xianglian Pingwei Powder plus Glutathione and Levofloxacin Hydrochloride on Patients with Liver Cirrhosis and Positive Small Intestinal Bacterial Overgrowth.

Authors:  Shanshan Su; Qingqing Wang; Fang Wei; Guoqi Zheng
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-11       Impact factor: 2.650

7.  Pharmacological treatments of Chinese herbal medicine for irritable bowel syndrome in adults: A network meta-analysis of randomized controlled trials.

Authors:  Yun-Bo Wu; Yun-Kai Dai; Ling Zhang; Huai-Geng Pan; Wei-Jing Chen; Ru-Liu Li; Ling Hu
Journal:  PLoS One       Date:  2021-08-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.